Chykingyoung Invt. Dev. Hldgs. Inc. (CHYI)

[rstar]

GOBK 0088 gingko. this looks interesting:
http://globalinkworld.com/equinox/resources/resources/pdfs/News%20-%20new%20development%20-%2014Apr2016.pdf
PRESS RELEASE
GLOBALINK, LTD. ANNOUNCES NEW DIRECTION & CURRENT COMPANY ACTIVITIES
VANCOUVER, BC, Canada - April 14, 2016 - Globalink, Ltd. (OTCQB: GOBK) (“Globalink”), announces that:
New Direction of Globalink Ltd.
Globalink is now focused on biotechnological developments of the healthcare maintenance system as a result of the presented opportunity from China to be able to eventually become one of the major participant suppliers of the 80% of the world's demand of the gingko leaf raw material for extraction. The extraction process is to retrieve the active essential ingredients, mainly, flavone glycosides and ginkolide from the leaves. These natural active ingredients in the leaves have the function to regulate cerebral blood flow, protection against free radicals and delaying the progress of memory loss and dementia. They can improve diabetes, cardio- cerebrovascular circulation, reduce triglyceride in the blood and many more other health benefits.
We are unique in the industry in that we will be the first to utilize modern scientific and technical procedures to control the growing cycle to produce stable high quality leaves and provide fingerprint information of each batch planted, harvested and sold. Our target is to add a further 1,450 acres or more to our plantation. If we achieve this size, we believe our operation would be among one of the largest independent producers of dried gingko leaves in China.
Current Event for Globalink Ltd
Throughout the month of March, 2016, our wholely-owned Chinese subsidiary Globalink (Xuzhou) Biotechnologies Co. Ltd, sowed 30,000,000 gingko biloba seedlings in our 100-acre test plot plantation in Pizhou, China. Our first harvest of the gingko leaves will be in September/October, 2016. The leaves will be dried and sold to pharmaceutical manufacturers for extraction of crucial ingredients needed for the manufacturing of healthcare products. At the current market value, the in-ground inventory is worth $3.36 million. Revenue expected from the 60 tons of dried leaves from the first harvest is $185,000, increasing to 450 tons at 1.38million the 2nd harvest and1500 tons at $4.62million the 3rd harvest, 4,500 tons at $14.77 million the 4th harvest, 5,580 tons at $17.17million each of the 5th, 6th and 7th harvest, there being 1 harvest in September/October every year. Beginning the 7th year, the mature gingko biloba trees in the 100 acre parcel would then be sold sector by sector for an anticipated gross revenue of approximately $250 million. The 100-acre test plot would then be re-sowed with new seedlings. By the end of the 4th year, we expect to complete acquisition of a further 1,450 acres to increase the size of the
plantation. We have signed letters of intent from world major pharmaceutical manufacturers to purchase our harvested and dried gingko leaves.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as "expects", "intends", "estimates", "projects", "anticipates", "believes", "could", and other similar words. All statements addressing product performance, events, or developments that Globalink, Ltd. expects or anticipates will occur in the future are forward-looking statements. Because the statements are forward-looking, they should be evaluated in light of important risk factors and uncertainties, some of which are described in Globalink, Ltd.’s Quarterly and Annual Reports filed with the United States Securities and Exchange Commission (the “SEC”) and British Columbia Securities Commission (the "SEDAR"). Should one or more of these risks or uncertainties materialize, or should any of Globalink, Ltd.'s underlying assumptions prove incorrect, actual results may vary materially from those currently anticipated. In addition, undue reliance should not be placed on Globalink, Ltd.'s forward-looking statements. Except as required by law, Globalink, Ltd. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. No stock exchange, securities commission or other regulatory body has reviewed nor accepts responsibility for the adequacy or accuracy of this release. Investors are advised to carefully review the reports and documents that Globalink, Ltd. files from time to time with the SEC and SEDAR, including its Annual, Quarterly and Current Reports.
Contact:
Robin Young, COO [phone]